Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine
Clinical trial NCT05107375 · COMPLETED
Trial details
- NCT number
- NCT05107375
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2022-03-04
- Enrollment
- 299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.